Cyclacel Pharmaceuticals (NASDAQ:CYCC) Earns Sell Rating from Analysts at StockNews.com
Equities researchers at StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Stock Performance NASDAQ CYCC opened at $0.32 on Friday. The stock has a market cap of $2.00 million, […]
Equities researchers at StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Stock Performance NASDAQ CYCC opened at $0.32 on Friday. The stock has a market cap of $2.00 million, […]
